A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center Trial of MBG-36 for the treatment of migraines in adult patients.
About the ICS Trial
MyMedCo is conducting the ICS Trial to determine effectiveness of the investigational medication migraine-b-gone (also called MBG-36) as a treatment option for people with migraines. The ICS Trial will assess whether migraine-b-gone decreases the number of migraines in patients.
The study has been reviewed and authorized by the FDA and is being conducted in the United States, Europe and Asia. For more information, please take a look at our Additional Information section below, visit clinicaltrials.gov or https://www.dontclickthisidkwhereitlinksto.com.
Trial Tech Medical 